Filing Details
- Accession Number:
- 0001225208-14-014154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-02 10:22:16
- Reporting Period:
- 2014-05-30
- Filing Date:
- 2014-06-02
- Accepted Time:
- 2014-06-02 10:22:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
105770 | West Pharmaceutical Services Inc | WST | Fabricated Rubber Products, Nec (3060) | 231210010 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205325 | D Richard Luzzi | 530 Herman O. West Drive Exton PA 19341 | Sr. Vp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-30 | 22,828 | $22.49 | 123,623 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-30 | 22,828 | $42.17 | 100,795 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-05-30 | 22,828 | $22.49 | 22,828 | $22.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-02-27 | 2018-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 956 | Indirect | By Savings Plan |
Common Stock | 9,193 | Indirect | Non-Qualified Deferred Compensation Plan |
Footnotes
- Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.